Filter News
Area of Research
News Topics
- (-) Biomedical (5)
- (-) Materials Science (2)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (3)
- Big Data (1)
- Bioenergy (7)
- Biology (13)
- Biotechnology (3)
- Buildings (1)
- Chemical Sciences (1)
- Clean Water (3)
- Climate Change (2)
- Computer Science (10)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (1)
- Environment (18)
- Exascale Computing (1)
- High-Performance Computing (8)
- Mercury (3)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (2)
- Physics (1)
- Quantum Computing (1)
- Quantum Science (1)
- Security (1)
- Summit (3)
- Sustainable Energy (5)
- Transportation (1)
Media Contacts
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.